Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Dahlmann, Mathias Dr. (2) Kobelt, Dennis Dr. (2) Mathas, Stephan Dr. (7) Reich, Jens Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (25) Schmitt, Clemens Prof. Dr. (1) Smith, Janice (3) Specker, Edgar Dr. (2) Stein, Ulrike Prof. Dr. (12) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (11) Wollert-Wulf, Brigitte (2) (-) Daniel, Peter Prof. Dr. (3) (-) Janz, Martin Dr. (7) (-) Lusatis, Simone (1) Bioinformatics (1) Bioinformatik der Genregulation (2) (-) Biologie maligner Lymphome (7) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Light Microscopy (BIMSB) (1) Molekulare Zellbiologie und Gentherapie (1) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (2) Proteom Dynamik (8) RNA Biologie und Posttranscriptionale Regulation (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) (-) Translationale Onkologie solider Tumore (2) 2003 (4) 2004 (2) 2005 (2) (-) 2006 (5) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (1) 2015 (2) 2016 (1) (-) 2017 (4) 2018 (1) 2019 (1) 2020 (4) 2021 (3) 2022 (6) 2023 (1) 9 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Lusatis, SimoneBiologie maligner LymphomeTranslationale Onkologie solider Tumore20062017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 13. Dezember 2017 in J Neurosci Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination S.V. Fazal J.A. Gomez-Sanchez L.J. Wagstaff N. Musner G. Otto M. Janz R. Mirsky K.R. Jessen 10. September 2017 in Canc Lett MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers H. Radhakrishnan K. Ilm W. Walther S. Shirasawa T. Sasazuki P.T. Daniel B. Gillissen U. Stein 01. April 2017 in Br J Haematol Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012) N. Baras S. Dahm J. Haberland M. Janz K. Emrich K. Kraywinkel A. Salama 01. März 2017 in Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 10. Mai 2006 in BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
13. Dezember 2017 in J Neurosci Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination S.V. Fazal J.A. Gomez-Sanchez L.J. Wagstaff N. Musner G. Otto M. Janz R. Mirsky K.R. Jessen
10. September 2017 in Canc Lett MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers H. Radhakrishnan K. Ilm W. Walther S. Shirasawa T. Sasazuki P.T. Daniel B. Gillissen U. Stein
01. April 2017 in Br J Haematol Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012) N. Baras S. Dahm J. Haberland M. Janz K. Emrich K. Kraywinkel A. Salama
01. März 2017 in Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
10. Mai 2006 in BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken